However, since AMPK-Ser485 is a target site of Akt47, comparable phosphorylation levels of Akt-Ser473 in OLETF and LETO after I/R (Fig. 5) argue against the involvement of this regulation in T2DM-induced suppression of AMPK. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.